StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer Collaborative arrangements by Year

Collaborative arrangements — Net profit/royalty sharing in Cost of sales (e.g., BioNTech Comirnaty 50% GP share) ($M) ($M)

Pfizer Collaborative arrangements: $2,181M in FY2025, down 24.8% from a year earlier.

Latest, FY2025
2,181
Period ended Dec 31, 2025
Change on a year earlier
-24.8%
2,901 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Collaborative Arrangements Footnote.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCollaborative arrangements — Net profit/royalty sharing in Cost of sales (e.g., BioNTech Comirnaty 50% GP share) ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,181-24.8%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 20242,901-32.2%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 20234,277-72.6%Form 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 202215,589-3.6%Form 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 202116,169+26,406.6%Form 10-K (filed 2024-02-22) ↗
FY2020Dec 31, 202061+17.3%Form 10-K (filed 2023-02-23) ↗
FY2019Dec 31, 201952+52.9%Form 10-K (filed 2022-02-24) ↗
FY2018Dec 31, 201834-89.7%Form 10-K (filed 2021-02-25) ↗
FY2017Dec 31, 2017329+4.4%Form 10-K (filed 2020-02-27) ↗
FY2016Dec 31, 2016315–Form 10-K (filed 2019-02-28) ↗

Cite this data

StockData. (2026). Pfizer Collaborative arrangements ($M), annual FY2016–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/collab-cogs

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.